Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Brian Sauer

Concepts (394)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1185
5.710
Why?
Antirheumatic Agents
24
2024
309
5.240
Why?
Veterans
32
2023
1650
3.610
Why?
Spondylitis, Ankylosing
5
2020
43
2.320
Why?
Hyperkalemia
3
2023
35
2.160
Why?
Veterans Health
8
2023
188
2.050
Why?
United States Department of Veterans Affairs
12
2021
777
1.810
Why?
Methotrexate
10
2021
234
1.750
Why?
Spondylarthritis
3
2020
50
1.220
Why?
Natural Language Processing
4
2023
103
1.190
Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
266
1.140
Why?
Rheumatology
2
2020
136
1.130
Why?
Biological Products
6
2021
258
1.110
Why?
Registries
18
2024
2400
1.090
Why?
Tumor Necrosis Factor-alpha
6
2024
1224
1.060
Why?
Medication Adherence
4
2019
535
1.000
Why?
Drug Substitution
3
2021
62
0.890
Why?
Psoriasis
2
2015
110
0.810
Why?
Arthritis, Psoriatic
3
2019
15
0.790
Why?
Lymphoma, Follicular
2
2021
57
0.780
Why?
Sulfasalazine
3
2019
22
0.760
Why?
Aged
46
2024
26432
0.760
Why?
Misoprostol
1
2022
15
0.720
Why?
Hydroxychloroquine
3
2019
65
0.720
Why?
HLA-B27 Antigen
3
2019
16
0.710
Why?
Lung Diseases, Interstitial
6
2024
677
0.690
Why?
Humans
97
2024
146342
0.680
Why?
Middle Aged
47
2024
36619
0.650
Why?
Databases, Factual
7
2018
1493
0.650
Why?
United States
31
2023
16136
0.640
Why?
Cohort Studies
16
2024
6077
0.630
Why?
Rituximab
2
2021
208
0.630
Why?
Electronic Health Records
6
2023
1210
0.630
Why?
Infliximab
3
2016
107
0.620
Why?
Pharmaceutical Services
2
2019
76
0.600
Why?
Insurance Claim Review
2
2017
87
0.600
Why?
Practice Patterns, Physicians'
5
2019
1408
0.600
Why?
Buprenorphine
1
2023
197
0.580
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
344
0.580
Why?
Analgesics, Opioid
5
2020
1221
0.580
Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
54
0.570
Why?
Algorithms
5
2020
1849
0.570
Why?
Arthritis
2
2021
97
0.570
Why?
Datasets as Topic
1
2019
120
0.560
Why?
Anemia, Iron-Deficiency
1
2019
61
0.550
Why?
Treatment Outcome
19
2024
11821
0.550
Why?
Severity of Illness Index
12
2023
2921
0.540
Why?
Etanercept
2
2016
60
0.540
Why?
Adalimumab
2
2016
53
0.530
Why?
Antineoplastic Agents, Immunological
1
2020
200
0.530
Why?
Male
54
2024
73396
0.530
Why?
Iron
2
2021
359
0.510
Why?
Kidney Failure, Chronic
1
2022
589
0.490
Why?
Chronic Pain
3
2022
304
0.470
Why?
Renal Insufficiency, Chronic
2
2021
640
0.470
Why?
Computer Simulation
4
2020
1014
0.460
Why?
Delivery of Health Care
2
2022
947
0.450
Why?
Drug Monitoring
4
2012
399
0.450
Why?
Female
49
2024
79499
0.450
Why?
Terminology as Topic
1
2017
253
0.440
Why?
Healthcare Common Procedure Coding System
1
2014
1
0.430
Why?
Cross-Over Studies
1
2017
615
0.430
Why?
Diabetes Mellitus
3
2024
1101
0.430
Why?
Polymers
3
2023
488
0.420
Why?
Risk Factors
23
2024
10921
0.420
Why?
Opioid-Related Disorders
1
2023
634
0.420
Why?
Research Design
3
2020
1143
0.420
Why?
Insurance, Pharmaceutical Services
2
2011
23
0.410
Why?
Adipokines
3
2022
56
0.410
Why?
Cytokines
5
2024
2081
0.400
Why?
Narcotics
1
2013
57
0.390
Why?
Models, Statistical
2
2017
669
0.380
Why?
Hospitalization
5
2021
2475
0.360
Why?
Utah
7
2013
82
0.360
Why?
Ambulatory Care
2
2014
628
0.360
Why?
Potassium
2
2023
151
0.360
Why?
Comparative Effectiveness Research
1
2013
171
0.360
Why?
Pharmaceutical Preparations
3
2022
172
0.350
Why?
Remission Induction
3
2022
308
0.350
Why?
Drug Prescriptions
2
2013
314
0.350
Why?
Medicine
1
2013
127
0.350
Why?
Emergency Service, Hospital
3
2023
2363
0.340
Why?
Time Factors
11
2021
7109
0.330
Why?
Drug Overdose
2
2012
377
0.330
Why?
Carpal Bones
2
2021
18
0.330
Why?
Proportional Hazards Models
8
2022
1331
0.330
Why?
Inflammatory Bowel Diseases
1
2015
352
0.310
Why?
Decision Support Systems, Clinical
2
2012
279
0.310
Why?
Cardiovascular Diseases
8
2023
2219
0.310
Why?
Disease Progression
2
2018
2867
0.310
Why?
Potentially Inappropriate Medication List
2
2020
17
0.310
Why?
Health Services Accessibility
2
2019
1107
0.310
Why?
Adiponectin
4
2024
243
0.300
Why?
Practice Guidelines as Topic
2
2019
1591
0.300
Why?
Quality Indicators, Health Care
1
2012
343
0.290
Why?
C-Reactive Protein
4
2021
429
0.290
Why?
Retrospective Studies
18
2023
17438
0.290
Why?
Kaplan-Meier Estimate
3
2021
970
0.270
Why?
Risk Assessment
10
2021
3712
0.270
Why?
Body Mass Index
6
2018
2458
0.260
Why?
Aged, 80 and over
13
2021
8391
0.260
Why?
Pneumonia, Bacterial
2
2020
114
0.260
Why?
Incidence
9
2024
2936
0.260
Why?
Antibodies, Monoclonal
1
2014
1512
0.250
Why?
Health Knowledge, Attitudes, Practice
2
2013
1408
0.250
Why?
Prospective Studies
9
2024
8123
0.250
Why?
ROC Curve
3
2019
617
0.250
Why?
International Classification of Diseases
4
2023
142
0.250
Why?
Arthrodesis
3
2021
38
0.240
Why?
Managed Care Programs
1
2007
137
0.230
Why?
Multimorbidity
2
2023
65
0.230
Why?
Predictive Value of Tests
4
2020
2113
0.230
Why?
Drug Utilization
2
2018
171
0.220
Why?
Drug Therapy, Combination
2
2019
1036
0.220
Why?
Embryo, Nonmammalian
2
2005
171
0.210
Why?
Propensity Score
3
2020
376
0.210
Why?
Patient Admission
1
2007
216
0.210
Why?
Gene Targeting
1
2004
76
0.210
Why?
Data Mining
3
2023
113
0.210
Why?
Alarmins
1
2024
27
0.210
Why?
Interleukin-33
1
2024
45
0.210
Why?
Regression Analysis
3
2018
999
0.200
Why?
Adult
16
2022
41087
0.200
Why?
Embryo, Mammalian
1
2004
230
0.200
Why?
Wrist
2
2021
60
0.190
Why?
Poisson Distribution
2
2017
77
0.190
Why?
Wrist Joint
2
2021
72
0.190
Why?
Polystyrenes
1
2023
38
0.190
Why?
Neurology
1
2024
107
0.180
Why?
Diclofenac
1
2022
14
0.180
Why?
Follow-Up Studies
7
2021
5439
0.180
Why?
Chemokines
2
2021
217
0.180
Why?
Weight Loss
2
2018
858
0.180
Why?
Neoplasms
5
2023
2954
0.180
Why?
Blood Sedimentation
2
2019
38
0.180
Why?
Comorbidity
4
2023
1665
0.180
Why?
Research Report
1
2022
89
0.180
Why?
Stroke
2
2021
1287
0.180
Why?
Confidence Intervals
2
2016
329
0.170
Why?
Rheumatic Diseases
1
2023
101
0.170
Why?
Polymerase Chain Reaction
1
2004
1031
0.170
Why?
Genetic Testing
1
2004
492
0.170
Why?
Linear Models
3
2018
857
0.170
Why?
Multivariate Analysis
5
2018
1543
0.160
Why?
Waldenstrom Macroglobulinemia
1
2021
20
0.160
Why?
Hospitals, Veterans
3
2018
256
0.160
Why?
Education, Medical
1
2024
274
0.160
Why?
Maintenance Chemotherapy
1
2020
41
0.160
Why?
Prescription Drugs
2
2012
110
0.160
Why?
Communication
2
2024
980
0.150
Why?
Cyclophosphamide
2
2021
275
0.150
Why?
Stem Cells
1
2004
613
0.150
Why?
Prosthesis-Related Infections
1
2021
100
0.150
Why?
Arthritis, Infectious
1
2021
77
0.150
Why?
Pneumonia, Staphylococcal
1
2020
26
0.150
Why?
Neoplasm Grading
1
2020
313
0.150
Why?
SEER Program
1
2020
233
0.150
Why?
Transferrin
1
2019
48
0.150
Why?
Ferritins
1
2019
69
0.140
Why?
Ranolazine
1
2018
23
0.140
Why?
Inappropriate Prescribing
1
2019
68
0.140
Why?
Bipolar Disorder
1
2021
285
0.140
Why?
Angina, Stable
1
2018
18
0.140
Why?
Area Under Curve
1
2019
335
0.140
Why?
Geriatrics
1
2019
96
0.140
Why?
Coronary Artery Disease
2
2022
751
0.130
Why?
Arthroplasty, Replacement, Hip
1
2021
193
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
195
0.130
Why?
Professional Practice Location
1
2017
26
0.130
Why?
Rheumatologists
1
2017
15
0.130
Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
253
0.130
Why?
Random Allocation
1
2018
366
0.130
Why?
Anti-Citrullinated Protein Antibodies
1
2019
129
0.130
Why?
Sacroiliitis
1
2017
7
0.130
Why?
Reverse Transcriptase Inhibitors
1
2018
89
0.130
Why?
Osteoarthritis
1
2020
206
0.130
Why?
Calcium Channel Blockers
1
2018
165
0.130
Why?
Heart Failure
2
2021
2329
0.130
Why?
Brain Ischemia
1
2021
362
0.130
Why?
Obesity, Abdominal
1
2017
48
0.130
Why?
Protease Inhibitors
1
2018
103
0.130
Why?
Longitudinal Studies
4
2023
3017
0.130
Why?
Bias
3
2013
197
0.130
Why?
Disability Evaluation
1
2018
297
0.120
Why?
Data Accuracy
1
2017
64
0.120
Why?
Population Surveillance
2
2012
481
0.120
Why?
Adrenergic beta-Antagonists
1
2018
253
0.120
Why?
Risk Management
2
2007
81
0.120
Why?
Neoplasm Metastasis
1
2019
693
0.120
Why?
HIV Integrase Inhibitors
1
2018
80
0.120
Why?
Leptin
3
2022
248
0.120
Why?
Recovery of Function
1
2021
725
0.120
Why?
Adverse Drug Reaction Reporting Systems
2
2007
81
0.120
Why?
Travel
1
2017
134
0.120
Why?
Forecasting
1
2018
388
0.120
Why?
Feasibility Studies
2
2020
1135
0.120
Why?
Pain
1
2022
790
0.120
Why?
Dose-Response Relationship, Radiation
1
2016
141
0.120
Why?
Hypertension
2
2018
1272
0.120
Why?
Anti-Inflammatory Agents
2
2018
474
0.120
Why?
Precision Medicine
1
2020
462
0.120
Why?
Neoplasm Staging
1
2020
1488
0.120
Why?
Prognosis
3
2020
4351
0.120
Why?
Fees, Pharmaceutical
1
2015
8
0.120
Why?
Antimicrobial Stewardship
1
2018
136
0.110
Why?
Drug Administration Routes
1
2015
41
0.110
Why?
Observational Studies as Topic
1
2016
133
0.110
Why?
Arthroplasty, Replacement, Knee
1
2021
385
0.110
Why?
Anti-Infective Agents
1
2018
234
0.110
Why?
Anti-Retroviral Agents
1
2018
250
0.110
Why?
Cross-Sectional Studies
6
2024
5899
0.110
Why?
Cyclosporine
1
2016
256
0.110
Why?
Cause of Death
4
2023
456
0.110
Why?
Pseudomonas Infections
1
2017
229
0.110
Why?
Hospital Mortality
1
2020
1051
0.110
Why?
Logistic Models
2
2018
2126
0.110
Why?
Health Care Costs
1
2018
423
0.110
Why?
Recombination, Genetic
3
2005
202
0.110
Why?
Inflammation Mediators
1
2017
508
0.110
Why?
Cross Infection
1
2017
258
0.100
Why?
Obesity
2
2018
3131
0.100
Why?
Suicide
1
2021
647
0.100
Why?
Drug Administration Schedule
1
2016
790
0.100
Why?
Glucocorticoids
1
2018
536
0.100
Why?
Health Expenditures
1
2015
198
0.100
Why?
Guideline Adherence
1
2018
594
0.100
Why?
Infusions, Intravenous
1
2014
432
0.100
Why?
Prednisone
3
2021
229
0.100
Why?
Quality Improvement
1
2022
1354
0.100
Why?
Causality
1
2013
128
0.090
Why?
Integrases
3
2005
117
0.090
Why?
Adiposity
1
2017
533
0.090
Why?
Diagnosis, Dual (Psychiatry)
1
2012
38
0.090
Why?
Telemedicine
1
2022
966
0.090
Why?
Education, Medical, Continuing
1
2013
130
0.090
Why?
Socioeconomic Factors
2
2018
1327
0.090
Why?
Root Cause Analysis
1
2012
11
0.090
Why?
Pneumonia
1
2018
635
0.090
Why?
Mortality
1
2015
375
0.090
Why?
Feedback
2
2023
183
0.090
Why?
Occupational Injuries
1
2012
49
0.090
Why?
HIV Infections
2
2018
3215
0.090
Why?
Florida
1
2012
117
0.090
Why?
Prescription Drug Misuse
1
2012
58
0.090
Why?
Lung Diseases
1
2018
787
0.090
Why?
HIV-1
1
2018
913
0.080
Why?
Lung Neoplasms
2
2022
2675
0.080
Why?
Outpatients
1
2014
440
0.080
Why?
Osteoporotic Fractures
1
2012
62
0.080
Why?
Risk
1
2013
920
0.080
Why?
Health Personnel
1
2017
754
0.080
Why?
Narration
1
2012
82
0.080
Why?
Antineoplastic Agents
1
2022
2219
0.080
Why?
Internal Medicine
1
2013
280
0.080
Why?
Adolescent
5
2015
22557
0.080
Why?
Reproducibility of Results
2
2016
3416
0.080
Why?
Dose-Response Relationship, Drug
1
2014
2022
0.080
Why?
Substance-Related Disorders
2
2023
1100
0.070
Why?
Blood Pressure
2
2018
1765
0.070
Why?
Anti-Bacterial Agents
1
2020
1942
0.070
Why?
Young Adult
3
2015
14330
0.070
Why?
Pattern Recognition, Automated
1
2008
74
0.070
Why?
Sex Factors
3
2021
2107
0.070
Why?
Diagnosis, Computer-Assisted
1
2008
92
0.070
Why?
Hospital Records
1
2007
10
0.070
Why?
Financing, Personal
1
2007
26
0.070
Why?
Catheter-Related Infections
1
2008
101
0.060
Why?
Cost Sharing
1
2007
23
0.060
Why?
Antihypertensive Agents
1
2011
519
0.060
Why?
Nonlinear Dynamics
1
2007
96
0.060
Why?
Biomarkers
3
2024
4340
0.060
Why?
Mutagenesis, Site-Directed
2
2005
371
0.060
Why?
Referral and Consultation
1
2013
881
0.060
Why?
Insulin-Like Growth Factor I
2
1999
320
0.060
Why?
Viral Proteins
2
1999
351
0.060
Why?
Machine Learning
2
2022
594
0.060
Why?
Primary Health Care
2
2013
1776
0.060
Why?
Drug Interactions
1
2007
405
0.060
Why?
Models, Theoretical
1
2008
561
0.050
Why?
Respiratory Tract Diseases
2
2017
178
0.050
Why?
Health Services Research
1
2007
390
0.050
Why?
Blotting, Southern
1
2004
82
0.050
Why?
Data Collection
1
2007
650
0.050
Why?
Inpatients
2
2024
540
0.050
Why?
Chronic Disease
2
2022
1827
0.050
Why?
Interleukin-17
1
2024
121
0.050
Why?
Artificial Intelligence
1
2008
389
0.050
Why?
Myocardial Infarction
1
2011
1215
0.050
Why?
Mass Screening
1
2012
1307
0.050
Why?
Mental Disorders
1
2012
1148
0.050
Why?
Vital Capacity
1
2023
293
0.050
Why?
Health Status
2
2018
827
0.050
Why?
Odds Ratio
2
2018
1077
0.050
Why?
Acetazolamide
1
2022
26
0.050
Why?
Telomere Shortening
1
2022
20
0.050
Why?
Antimanic Agents
1
2021
14
0.040
Why?
Lithium
1
2021
38
0.040
Why?
Valproic Acid
1
2021
45
0.040
Why?
Medicare
1
2007
920
0.040
Why?
Medication Therapy Management
1
2022
73
0.040
Why?
Length of Stay
1
2007
1358
0.040
Why?
Chlorambucil
1
2021
11
0.040
Why?
Vidarabine
1
2021
32
0.040
Why?
Bendamustine Hydrochloride
1
2021
18
0.040
Why?
Bortezomib
1
2021
54
0.040
Why?
Pulmonologists
1
2020
14
0.040
Why?
Patient Discharge
2
2023
997
0.040
Why?
Zebrafish
1
2005
536
0.040
Why?
Data Display
1
2020
20
0.040
Why?
Vincristine
1
2021
148
0.040
Why?
Quality Control
1
2020
163
0.040
Why?
Computed Tomography Angiography
1
2021
151
0.040
Why?
Cerebrovascular Circulation
1
2022
293
0.040
Why?
Embryonic and Fetal Development
1
1999
90
0.040
Why?
User-Computer Interface
1
2020
168
0.040
Why?
Bone Marrow Transplantation
1
2020
301
0.040
Why?
Piperidines
1
2021
225
0.040
Why?
Magnetic Resonance Angiography
1
2021
249
0.040
Why?
Pharmacists
1
2022
260
0.040
Why?
Range of Motion, Articular
1
2021
446
0.040
Why?
Magnetic Resonance Imaging
2
2022
3926
0.040
Why?
Telomere
1
2022
300
0.040
Why?
Dexamethasone
1
2021
368
0.030
Why?
Doxorubicin
1
2021
416
0.030
Why?
Adenine
1
2021
339
0.030
Why?
Gene Dosage
1
1998
146
0.030
Why?
Patient Satisfaction
1
2022
706
0.030
Why?
Cost-Benefit Analysis
1
2020
640
0.030
Why?
Methicillin Resistance
1
2017
17
0.030
Why?
Infant Mortality
1
1998
127
0.030
Why?
Gene Expression Regulation, Developmental
2
1999
902
0.030
Why?
Recurrence
1
2020
1133
0.030
Why?
HIV Integrase
1
2018
74
0.030
Why?
Reoperation
1
2020
645
0.030
Why?
Time-to-Treatment
1
2019
257
0.030
Why?
Rheumatic Nodule
1
2016
3
0.030
Why?
Cardiovascular Agents
1
2018
165
0.030
Why?
Absorptiometry, Photon
1
2017
278
0.030
Why?
Isoxazoles
1
2016
57
0.030
Why?
Nutrition Surveys
1
2017
270
0.030
Why?
Thinness
1
2016
100
0.030
Why?
Body Weight
2
2016
968
0.030
Why?
Critical Illness
1
2022
908
0.030
Why?
Rheumatoid Factor
1
2016
177
0.030
Why?
Viral Load
1
2018
526
0.030
Why?
Survival Analysis
1
2018
1378
0.030
Why?
Community-Acquired Infections
1
2017
179
0.030
Why?
Analysis of Variance
1
2018
1298
0.030
Why?
Peptides, Cyclic
1
2016
276
0.030
Why?
Lymphoma
1
2016
251
0.030
Why?
Leukemia
1
2016
246
0.030
Why?
Surveys and Questionnaires
2
2020
6073
0.030
Why?
Age Factors
1
2021
3347
0.020
Why?
Quality of Health Care
1
2018
702
0.020
Why?
Life Style
1
2016
496
0.020
Why?
Workers' Compensation
1
2012
28
0.020
Why?
Tomography, X-Ray Computed
1
2023
2786
0.020
Why?
Coroners and Medical Examiners
1
2011
8
0.020
Why?
Sampling Studies
1
2011
97
0.020
Why?
Death Certificates
1
2011
32
0.020
Why?
Inflammation
1
2022
2919
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1998
0.020
Why?
Brain
1
2022
2991
0.020
Why?
Smoking
1
2016
1486
0.020
Why?
Prostatic Neoplasms
1
2016
972
0.020
Why?
Pancreatic Neoplasms
1
2016
944
0.020
Why?
Medical Assistance
1
2007
14
0.020
Why?
Models, Econometric
1
2007
35
0.020
Why?
Psychoses, Substance-Induced
1
2007
16
0.020
Why?
Deductibles and Coinsurance
1
2007
13
0.020
Why?
Evidence-Based Medicine
1
2011
731
0.020
Why?
Eligibility Determination
1
2007
73
0.020
Why?
Quality of Life
1
2019
3200
0.020
Why?
Costs and Cost Analysis
1
2007
217
0.020
Why?
Child
1
2007
22693
0.020
Why?
Delirium
1
2007
107
0.010
Why?
Insurance Coverage
1
2007
248
0.010
Why?
beta-Galactosidase
1
2005
73
0.010
Why?
Blood Coagulation Disorders
1
2007
190
0.010
Why?
HSP70 Heat-Shock Proteins
1
2005
76
0.010
Why?
Mosaicism
1
2005
67
0.010
Why?
Genes, Reporter
1
2005
275
0.010
Why?
Animals, Genetically Modified
1
2005
248
0.010
Why?
Sensitivity and Specificity
1
2008
1998
0.010
Why?
Mice, Transgenic
2
1999
2134
0.010
Why?
Case-Control Studies
1
2011
3647
0.010
Why?
Recombinant Fusion Proteins
1
2005
663
0.010
Why?
Hemorrhage
1
2007
825
0.010
Why?
Liver
2
1999
1864
0.010
Why?
Growth Disorders
1
1998
89
0.010
Why?
Animals
3
2005
38107
0.010
Why?
Mice
2
1999
18297
0.010
Why?
RNA, Messenger
1
1998
2791
0.000
Why?
Infant, Newborn
1
1998
6460
0.000
Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)